Carmell Therapeutics received U.S. Patent No. 9,364,503, broadly covering the use of plasma-based materials to deliver drugs and proteins to an injured site.
Centric Medical received FDA 510(k) clearance to market the Subtalar Arthroereisis Implant. Limited release will occur at the end of 2016, with full launch following in 1Q17.
During 1H16, seven of the eight largest orthopaedic device companies confirmed or completed acquisitions or divestitures spanning nearly every orthopaedic market segment. Here we present a full list of M&A transactions from the first half of the year.
ORTHOWORLD reported 18 funding announcements in 1H16, compared to 23 in 1H15. Similar to recent years, the spine market was the largest target for funding.
MedShape announced that a U.S. District Court ruled to invalidate key claims of a Cayenne Medical patent. Cayenne Medical agreed to withdraw allegations of patent infringement and end litigation on the matter, and MedShape withdrew challenges to the validity of Cayenne Medical’s patent claims.
Aurora Spine was issued U.S. Patent No. 9,364,264, "Dynamic and Non-Dynamic Interspinous Fusion Implant and Bone Growth Stimulation System," covering ZIP® devices including ZIP Ultra®, ZIP 51™, ZIP LP™, Dyna-ZIP™, etc.